71 – 80 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine
- Contribution to journal › Article
-
Mark
Pain over 2 years after start of biological versus conventional combination treatment in early rheumatoid arthritis : results from the randomised controlled SWEFOT trial
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
- Contribution to journal › Article
-
Mark
Association between serum urate and CSF markers of Alzheimer's disease pathology in a population-based sample of 70-year-olds
- Contribution to journal › Article
-
Mark
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden : From infection severity to impact on care provision
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
- Contribution to journal › Article
-
Mark
Consultation prevalence among children, adolescents and young adults with pain conditions : A description of age- And gender differences
- Contribution to journal › Article
-
Mark
“Mastering a New Life Situation” – Patients’ Preferences of Treatment Outcomes in Early Rheumatoid Arthritis – A Longitudinal Qualitative Study
- Contribution to journal › Article
-
Mark
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- Contribution to journal › Article
-
Mark
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
- Contribution to journal › Article
